Feb. 2, 2026Biopharma money raised: Jan. 1-30, 2026Year-to-date money raised in public, private and other financings of biopharma companies.
Feb. 2, 2026Money raised by biopharmaTotal raised in public, private and other financings of biopharma companies, comparing 2019-2026.
Feb. 2, 2026Regulatory actions for Feb. 2, 2026Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Chiesi, Eli Lilly, Johnson & Johnson, Protalix, Sanofi, Ultragenyx, Unicycive.
